Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -0.36EBITDA per Share
VS
Market
Sector
Industry
History
$ 10.36Close
$ 2.49 - $ 10.63 52-Week Range
Ticker Information
Ticker
TRVICompany Name
TREVI THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTREVI THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TRVI - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -47.19M | $ -0.36 | 1 | 130.35M |
| 3/31/2025 | $ -47.23M | $ -0.4 | 1 | 117.61M |
| 12/31/2024 | $ -47.79M | $ -0.47 | 1 | 101.97M |
| 9/30/2024 | $ -44.2M | $ -0.44 | 1 | 101.28M |
| 6/30/2024 | $ -38.63M | $ -0.38 | 1 | 101.04M |
| 3/31/2024 | $ -33.3M | $ -0.33 | 1 | 99.52M |
| 12/31/2023 | $ -28.58M | $ -0.29 | 1 | 99.03M |
| 9/30/2023 | $ -26.05M | $ -0.26 | 1 | 99.33M |
| 6/30/2023 | $ -26.35M | $ -0.27 | 1 | 98.7M |
| 3/31/2023 | $ -27.12M | $ -0.28 | 1 | 98.61M |
Key Performance Insights, Last 5 Years
- TREVI THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -1.63.
- Over the past 5 years, TREVI THERAPEUTICS INC's average EBITDAPS has been $ -0.78.
- The median EBITDAPS for TREVI THERAPEUTICS INC during this period was $ -0.44
- TREVI THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -0.26.
- The lowest EBITDAPS recorded by TREVI THERAPEUTICS INC in the same timeframe $ -1.79
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for TREVI THERAPEUTICS INC is calculated as follows: EBITDA [ $ -29.62M ] / (Shares WA [ 18.13M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -1.63 ] TRVI - EBITDA per Share, Last 5 years
$ -1.79
Minimum
Dec 31, 2020
$ -0.26
Maximum
Sep 30, 2023
$ -0.78
Average
$ -0.44
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -10.86 |
| max | $ 13.95 |
| average | $ 2.01 |
| median | $ 0.99 |
| std | $ 4.26 |